Echo Life Sciences Fund, LP — Form D/A
Echo Life Sciences Fund, LP of OKLAHOMA CITY, OK, a pooled investment fund, filed a Form D amendment with the SEC on 2022-07-14. The offering totals $150.0M, of which $7.3M was reported sold. Industry: Pooled Investment Fund.
Offering
- Filed: 2022-07-14
- Form: D/A
- Accession: 0001860720-22-000002
- Industry: Pooled Investment Fund
- Exemptions: 06b, 3C, 3C.1
- Total offering: $150.0M
- Amount sold: $7.3M
- Remaining: $142.7M
- Investors: 8
- Date of first sale: 2021-08-16
- Security types: fund interests
- Revenue range: Decline to Disclose
- SEC file number: 021-409181
Issuer
- Name: Echo Life Sciences Fund, LP
- CIK: 0001860720
- Entity type: Limited Partnership
- Jurisdiction: DELAWARE
- Incorporated: 2021
- Address: 120 ROBERT S. KERR, SUITE 701, OKLAHOMA CITY, OK, 73102
- Phone: 405-225-2380
Officers, directors & promoters (4)
| Name | Role | Location |
|---|
| Brandon Christian O'Gara | Executive Officer | Oklahoma City, OK |
| n/a Echo O-Bio Fund I GP, LLC | Promoter | Oklahoma City, OK |
| Michael Christian Kanady | Executive Officer | Oklahoma City, OK |
| n/a Echo Investment Capital, LLC | Executive Officer | Oklahoma City, OK |
Other filings by this issuer (2)
More